Merck patents on Hepatitis C treatment found valid in dispute with Gilead
 

Merck patents on Hepatitis C treatment found valid in dispute with Gilead
NEW YORK, March 22 (Reuters) - A federal jury on Tuesday upheld the validity of two Merck & Co patents in a high-profile dispute with rival Gilead Sciences Inc, which could be forced to hand over a portion of the billions of dollars in revenue from its blockbuster cure for hepatitis C.


http://rc.feedsportal.com/r/24739554...28/rc/1/rc.img

http://rc.feedsportal.com/r/24739554...28/rc/2/rc.img

http://rc.feedsportal.com/r/24739554...28/rc/3/rc.img

http://da.feedsportal.com/r/24739554...1/sc/28/a2.img
http://adchoice.feedsportal.com/r/24.../sc/28/ach.imghttp://pi.feedsportal.com/r/24739554.../sc/28/a2t.imghttp://pi2.feedsportal.com/r/2473955...sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...tE:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...tE:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/vN1hBsAYtjk